IRIS
Pizzato, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.964
AS - Asia 1.152
EU - Europa 995
SA - Sud America 289
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 6.434
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.927
SG - Singapore 619
IT - Italia 271
CN - Cina 269
BR - Brasile 239
RU - Federazione Russa 181
VN - Vietnam 100
UA - Ucraina 97
FI - Finlandia 77
DE - Germania 74
GB - Regno Unito 67
LV - Lettonia 59
SE - Svezia 53
IN - India 29
NL - Olanda 28
ID - Indonesia 26
AR - Argentina 22
CA - Canada 20
AT - Austria 18
HK - Hong Kong 18
TR - Turchia 18
BD - Bangladesh 15
FR - Francia 13
PL - Polonia 12
JP - Giappone 11
EC - Ecuador 10
MX - Messico 10
IQ - Iraq 8
ZA - Sudafrica 8
CL - Cile 7
CZ - Repubblica Ceca 6
ES - Italia 6
JO - Giordania 6
VE - Venezuela 6
BG - Bulgaria 5
PK - Pakistan 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
HU - Ungheria 4
LT - Lituania 4
TN - Tunisia 4
BY - Bielorussia 3
CR - Costa Rica 3
EG - Egitto 3
TW - Taiwan 3
AL - Albania 2
CH - Svizzera 2
CO - Colombia 2
EU - Europa 2
GR - Grecia 2
IE - Irlanda 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
NO - Norvegia 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BO - Bolivia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GM - Gambi 1
HN - Honduras 1
IL - Israele 1
KR - Corea 1
MK - Macedonia 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
PY - Paraguay 1
RS - Serbia 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
UY - Uruguay 1
YT - Mayotte 1
Totale 6.434
Salva come PNG Salva come JPEG
Città #
Fairfield 508
Ashburn 451
Singapore 401
Chandler 281
Woodbridge 249
Seattle 228
Jacksonville 220
Wilmington 192
Cambridge 176
Houston 165
Santa Clara 130
Dallas 129
Columbus 103
Ann Arbor 96
Moscow 86
Trento 85
Princeton 84
San Mateo 81
Los Angeles 62
New York 60
Riga 59
Beijing 57
Munich 38
Ho Chi Minh City 32
Boardman 31
Helsinki 27
Chicago 26
Como 26
San Diego 25
São Paulo 24
Rome 22
Jakarta 21
London 21
Dearborn 20
Hanoi 19
Buffalo 18
The Dalles 18
Hong Kong 17
Orem 17
Council Bluffs 16
Hefei 16
Redondo Beach 15
Chennai 12
Dong Ket 12
Warsaw 12
Milan 11
Tokyo 11
Vienna 11
Montreal 10
Brooklyn 9
Lappeenranta 9
San Paolo di Civitate 9
Verona 9
Guangzhou 8
Poplar 8
San Jose 8
Falkenstein 7
Izmir 7
Johannesburg 7
Turku 7
Amsterdam 6
Denver 6
Elk Grove Village 6
Jinan 6
Nuremberg 6
Stockholm 6
Turin 6
Washington 6
Belo Horizonte 5
Brasília 5
Bremen 5
Fort Worth 5
Frankfurt am Main 5
Fremont 5
Mexico City 5
Mumbai 5
Phoenix 5
Quito 5
Salt Lake City 5
Sofia 5
Tashkent 5
Toronto 5
Brno 4
Brugherio 4
Düsseldorf 4
Miami 4
New Delhi 4
Rio de Janeiro 4
Riva Del Garda 4
San Francisco 4
Shenzhen 4
Tampa 4
Volargne 4
Atlanta 3
Baghdad 3
Boston 3
Budapest 3
Buenos Aires 3
Changsha 3
Da Nang 3
Totale 4.702
Salva come PNG Salva come JPEG
Nome #
SERINC5 as a new restriction factor for human immunodeficiency virus and murine leukemia virus 190
A bipartite structural organization defines the SERINC family of HIV-1 restriction factors 185
SARS-CoV-2 and the Host Cell: A Tale of Interactions 177
SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins 172
A Community Study of SARS-CoV-2 Detection by RT-PCR in Saliva: A Reliable and Effective Method 172
HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation 169
Retroviral factors promoting infectivity. 156
The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists 154
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 151
Galanin pathogenic mutations in temporal lobe epilepsy 149
Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells. 148
The antagonism of HIV Nef to SERINC5 particle infectivity restriction involves the counteraction of virion-associated pools of the restriction factor 148
The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild 146
Gene Therapy of Glioblastoma Multiforme with a Bicistronic Retroviral Vector Expressing Human IL-2 and HSV-tK. 144
Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans. 143
S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3 143
Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration 143
The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles 142
Effect of High-Energy Milling on the Dissolution of Anti-HIV Drug Efavirenz in Different Solvents 136
Mechanical activation of Efavirenz: the effects on the dissolution and inhibitory behavior 133
Centriolar distal appendages activate the centrosome-PIDDosome-p53 signalling axis via ANKRD26 132
Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef. 128
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer 123
Effect of differential growth conditions on the dTTP pool size in herpes simplex virus-infected Vero cells. 121
TRIM5 is an innate immune sensor for the retrovirus capsid lattice. 117
A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants. 116
Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry. 115
Cyclosporine blocks incorporation of HIV-1 envelope glycoprotein into virions. 113
Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors. 113
Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles. 108
Progress with retroviral gene vectors. 108
Heparin binds to murine leukemia virus and inhibits Env-independent attachment and infection. 104
Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors. 103
Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75. 102
Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. 100
Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix. 99
Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41. 98
Determination of HPRT mutant frequency and molecular analysis of T-lymphocyte mutants derived from coke-oven workers. 98
The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α. 98
Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer. 96
Viral particles imaging through evanescent wave scattering in a total internal reflection laser microscope 94
MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1. 94
Localization to detergent-resistant membranes and HIV-1 core entry inhibition correlate with HIV-1 restriction by SERINC5 93
Herpes simplex virus chronically infected human T lymphocytes are susceptible to HIV-1 superinfection and support HIV-1 pseudotyping. 88
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine 85
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity 83
The activity of Nef on HIV-1 infectivity. 83
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals 80
Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity 72
Host Restriction Factors Modulating HIV Latency and Replication in Macrophages 69
Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. 66
Retrovirus vectors. 63
The impact of infection risk communication format on tourism travel intentions during COVID-19 60
A Conserved Acidic Residue in the C-Terminal Flexible Loop of HIV-1 Nef Contributes to the Activity of SERINC5 and CD4 Downregulation 59
Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals 54
Prospective epidemiological, molecular, and genetic characterization of a novel coronavirus disease in the Val Venosta/Vinschgau: the CHRIS COVID-19 study protocol 53
Trends and symptoms of SARS-CoV-2 infection: a longitudinal study on an Alpine population representative sample 51
Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity 46
A two-step ion-exchange process for modified mechanical reinforcement and virucidal functionalization of glasses 1
Totale 6.587
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 469
Totale 29.327
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021376 0 0 0 0 0 0 48 56 46 74 99 53
2021/2022481 22 32 8 20 12 31 7 106 48 49 59 87
2022/2023607 63 68 6 69 52 87 9 54 113 35 31 20
2023/2024332 20 20 18 20 34 84 21 22 5 13 12 63
2024/20251.332 17 11 75 247 79 166 115 82 137 234 76 93
2025/20261.623 184 82 330 476 362 186 3 0 0 0 0 0
Totale 6.587